- Report
- November 2023
- 78 Pages
France
From €3081EUR$3,500USD£2,663GBP
- Report
- December 2022
- 115 Pages
Global
From €3962EUR$4,500USD£3,424GBP
- Report
- November 2023
- 77 Pages
France
From €3081EUR$3,500USD£2,663GBP
- Report
- May 2024
- 279 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- January 2024
- 200 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- December 2024
- 175 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- November 2024
- 338 Pages
Global
From €4402EUR$5,000USD£3,804GBP
- Report
- June 2021
Global
From €3521EUR$4,000USD£3,044GBP
- Report
- February 2024
- 200 Pages
Global
From €6603EUR$7,500USD£5,707GBP
- Report
- November 2023
- 120 Pages
Asia Pacific
From €3521EUR$4,000USD£3,044GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €2641EUR$3,000USD£2,283GBP
- Report
- December 2024
- 200 Pages
Global
From €3301EUR$3,750USD£2,853GBP
- Report
- December 2024
- 200 Pages
Global
From €3301EUR$3,750USD£2,853GBP
- Report
- December 2024
- 200 Pages
Global
From €3301EUR$3,750USD£2,853GBP
- Report
- October 2024
- 200 Pages
Global
From €3301EUR$3,750USD£2,853GBP
- Report
- May 2024
- 200 Pages
Global
From €3654EUR$4,150USD£3,158GBP
- Report
- May 2024
- 200 Pages
Global
From €3654EUR$4,150USD£3,158GBP
- Report
- May 2024
- 200 Pages
Global
From €3654EUR$4,150USD£3,158GBP
- Report
- October 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,397GBP
- Report
- August 2023
- 145 Pages
Global
From €2773EUR$3,150USD£2,397GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more